WASHINGTON — There’s an unlikely kumbaya in Washington this year: both President Trump and House Speaker Nancy Pelosi have made it clear that lowering the cost of prescription drugs is among their top priorities.

But with a fiercely resistant pharmaceutical lobby, an unpredictable White House, and split control of Congress, can 2019 be the year something finally gets done?

STAT’s Washington correspondents Lev Facher and Nicholas Florko explore these questions and fielded more on this hot-button issue.

advertisement

Download slides here (PDF). You may view the webinar recording below.

  • I CAME TO YOUR SITE TO RETRIEVE SLIDES AND ACCESS THE VIDEO WEBINAR ONLY TO FIND THAT THE ONLY WAY TO ACCESS THESE WAS TO JOIN STAT PLUS!

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy